CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The Overexpression of NUSAP1 and GTSE1 Could Predict An Unfavourable Prognosis and Shorter Disease Free Survival in ccRenal Cell Carcinoma.
The Overexpression of NUSAP1 and GTSE1 Could Predict An Unfavourable Prognosis and Shorter Disease Free Survival in ccRenal Cell Carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们证明 NUSAP1 和 GTSE1 过表达与 ccRCC 的不良预后临床病理特征密切相关,并预示不良预后。因此,NUSAP1 和 GTSE1 可能共同作为 ccRCC 患者潜在的未来预后指标和治疗靶点。然而,仍需在更大规模的分子研究中进行进一步分析,以阐明这两个标志物之间的交互串扰调控机制及其对 ccRCC 的联合效应。
尽管已有报道称 NUSAP1 和 GTSE1 在不同类型的肿瘤中高表达,并与恶性进展和不良临床预后相关,但其在 ccRCC 中与临床病理数据的意义及与患者生存的相关性仍知之甚少。因此,在我们的研究中,我们试图评估 NUSAP1 和 GTSE1 在 ccRCC 中的联系,并将其免疫表达与临床病理参数和患者生存进行关联,以确定其作为潜在治疗靶点、肿瘤进展指标和患者预后的意义。
采用免疫组织化学方法对100例ccRCC患者中的NUSAP1和GTSE1进行检测。评估NUSAP1和GTSE1免疫反应性与临床病理变量之间的关联。采用Kaplan-Meier法检测无病生存期(DFS)。采用多因素Cox回归评估这两种蛋白的预后作用。
我们分别在60%和62%的病例中检测到NUSAP1和GTSE1高表达。NUSAP1和GTSE1免疫表达与大小(分别为p=0.007和p=0.026)、Fuhrman分级(分别为p=0.022和p=0.004)、肿瘤分期(分别为p=0.003和p=0.019)、TILs(分别为p=0.026和p=0.04)、包膜侵犯(分别为p=0.002和p=0.009)、远处转移(分别为p=0.007和p=0.009)以及DFS(分别为p=0.007和0.009)之间存在显著关联。多因素Cox回归显示,NUSAP1和GTSE1高表达水平与ccRCC病例的不良预后独立相关。
Although it has been reported that NUSAP1 and GTSE1 are highly expressed in different types of tumors and associated with malignant progression and poor clinical prognosis, their significances with clinicopathological data and correlations with patients' survival in ccRCC are still poorly understood. Therefore, in our study we attempted to evaluate the link between NUSAP1 and GTSE1 in ccRCC and to correlate their immunoexpression with clinico-pathological parameters and the patients' survival to identify their significance as potential therapeutic targets, indicators for tumor progression, and patients' prognosis. METHOD: NUSAP1 and GTSE1 were examined in 100 ccRCC patients by immunohistochemistry. The association between NUSAP1 and GTSE1 immunoreactivity and clinicopathological variables were evaluated. The disease free survival (DFS) was examined by the Kaplan-Meier method. The multivariate Cox regressions was estimated to detect the prognostic role of both proteins.
We detected high NUSAP1 and GTSE1 expression in 60% and 62% of the cases, respectively. A significant association was detected between NUSAP1 and GTSE1 immunoexpression and size (p=0.007 and p=0.026, respectively), Fuhrman grade (p=0.022 and p=0.004, respectively), tumor stage (p=0.003 and p=0.019, respectively), TILs (p=0.026 and p=0.04 respectively), capsular invasion (p=0.002 and p=0.009, respectively), Distant metastasis (p=0.007 and p=0.009, respectively), and DFS (p=0.007 and 0.009, respectively). Multivariate Cox regression showed that high NUSAP1 and GTSE1 expression levels were independently associated with an unfavourable poor prognosis of ccRCC cases.
We demonstrated that NUSAP1 and GTSE1 overexpression was closely related to the poor prognostic clinicopathological features of ccRCC and predicted an unfavorable prognosis. Therefore, NUSAP1 and GTSE1 might act together as potential futuristic prognostic indicators and therapeutic targets for ccRCC patients. However, further analysis in molecular studies on larger scale are mandatory to highlight the interactive crosstalk regulatory mechanisms between both markers and their combined effect on ccRCC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。